D

$DOC

3 articles found
1 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Zealand Pharma

Zealand Pharma Plants U.S. Flag in Cambridge with $M Research Hub by 2026

Zealand Pharma opens Cambridge research hub in September 2026 to expand AI-driven drug discovery and develop next-generation hybrid molecule therapeutics.
ZLDPYDOCpeptide therapeuticsobesity
The Motley FoolThe Motley Fool··Selena Maranjian

High Yields Beckon: Can Campbell's, Healthpeak, and Kraft Heinz Deliver for Income Investors?

Three S&P 500 stocks offer 6.9%-7.4% yields amid significant declines. Campbell's, Kraft Heinz, and Healthpeak Properties may offer value, but thorough due diligence is essential.
KHCCPBDOCstock valuationS&P 500
Investing.comInvesting.com··Brett Owens

Healthcare Stocks Hit Geopolitical Headwinds While Dividend Yields Soar to 14.1%

Healthcare sector faces pullback amid Middle East tensions, but dividend-paying stocks and funds offer yields of 6-14.1% with varying risk profiles.
PFEAREDOCbiotechGLP-1 drugs